<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03554187</url>
  </required_header>
  <id_info>
    <org_study_id>Pil-Clin-BuccP-016</org_study_id>
    <secondary_id>2017-A02945-48</secondary_id>
    <nct_id>NCT03554187</nct_id>
  </id_info>
  <brief_title>Efficacy of Supplementation With Probiotics as Adjuvant to Mechanical Treatment in Chronic Periodontitis</brief_title>
  <official_title>Efficacy of Supplementation With Probiotics as Adjuvant to Mechanical Treatment in Chronic Periodontitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pileje</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pileje</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It aims to demonstrate the superiority of a 6-week supplementation with Lactibiane
      Buccodental compared to placebo, as adjunctive therapy in chronic periodontitis in patients
      with generalized chronic periodontitis
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 22, 2018</start_date>
  <completion_date type="Anticipated">May 22, 2019</completion_date>
  <primary_completion_date type="Anticipated">May 22, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean level of clinical attachment (CAL)</measure>
    <time_frame>up to 3 months</time_frame>
    <description>Clinical Attachment (CAL) of parondontal pocket ; measurement with Florida Probe in millimeters</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quantitative evolution of Aggregatibacter actinomycetemcomitans (Aa) bacteria</measure>
    <time_frame>day -14, day 1, day 45, day 90</time_frame>
    <description>measured from a non-invasive sample in the parontal pocket. Result expressed in number of bacteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative evolution of Porphyromonas gingivalis (Pg) bacteria</measure>
    <time_frame>day -14, day 1, day 45, day 90</time_frame>
    <description>measured from a non-invasive sample in the parontal pocket. Result expressed in number of bacteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative evolution of Tannerella forsythia (Tf) bacteria</measure>
    <time_frame>day -14, day 1, day 45, day 90</time_frame>
    <description>measured from a non-invasive sample in the parontal pocket. Result expressed in number of bacteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative evolution of Treponema denticola (Td) bacteria</measure>
    <time_frame>day -14, day 1, day 45, day 90</time_frame>
    <description>measured from a non-invasive sample in the parontal pocket. Result expressed in number of bacteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative evolution of Prevotella intermedia (Pi) bacteria</measure>
    <time_frame>day -14, day 1, day 45, day 90</time_frame>
    <description>measured from a non-invasive sample in the parontal pocket. Result expressed in number of bacteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative evolution of Fusobacterium nucleatum (Fn) bacteria</measure>
    <time_frame>day -14, day 1, day 45, day 90</time_frame>
    <description>measured from a non-invasive sample in the parontal pocket. Result expressed in number of bacteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evolution of several oral indices : Pocket depth</measure>
    <time_frame>day -14, day 1, day 45, day 90</time_frame>
    <description>pocket depth in millimeters (measured with Florida Probe)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evolution of several oral indices : Gingival recession</measure>
    <time_frame>day -14, day 1, day 45, day 90</time_frame>
    <description>gingival recession in millimeters (measured with Florida Probe)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evolution of several oral indices : Gingival bleeding on probing</measure>
    <time_frame>day -14, day 1, day 45, day 90</time_frame>
    <description>gingival bleeding on probing (Florida Probe) in percentage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evolution of halitosis</measure>
    <time_frame>day -14, day 1, day 45, day 90</time_frame>
    <description>In expired breath : Volatil Sulfur Compounds (in ppm) measure with Halimeter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall clinical course of periodontitis</measure>
    <time_frame>day -14, day 1, day 45, day 90</time_frame>
    <description>according to the dentist, in habitual practise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety (tolerance to treatment)</measure>
    <time_frame>up to a year</time_frame>
    <description>calculated with adverse events that may be observed during study period (descriptif results)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate adherence to treatment</measure>
    <time_frame>up to a year</time_frame>
    <description>Quick estimation at D+90</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">54</enrollment>
  <condition>Probiotics, Periodontitis</condition>
  <arm_group>
    <arm_group_label>Lactibiane Buccodental, probiotics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>For one tablet : Lactobacillus paracasei LA 802 (109 UFC), Vitamine D3 (1,5 µg), Vitamine C (24 mg) Dosage : 2 tablets daily for 6 weeks tablet to suck after the meal and brushing teeth (one in the morning and one in the evening)
Interventions :
Ultrasonic periodontal debridement, with appropriate device : D+1 / Analyzes of periodontopathogenic bacteria : D-14, D+1, D+45, D+90 / IL1B test : D-14 / Salivary sampling : D+1, D+45, D+90 / Halitosis measure : D+1, D+45, D+90</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>With no metabolic action ; identical in appearance to experimental probiotics Dosage : 2 placebo tablets daily for 6 weeks tablet to suck after the meal and brushing teeth (one in the morning and one in the evening)
Intervention(s) :
Ultrasonic periodontal debridement, with appropriate device : D+1 / Analyzes of periodontopathogenic bacteria : D-14, D+1, D+45, D+90 / IL1B test : D-14 / Salivary sampling : D+1, D+45, D+90 / Halitosis measure : D+1, D+45, D+90</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasonic periodontal Debridement, with appropriate device</intervention_name>
    <description>Dental procedure that includes therapeutic interventions such as scaling to remove calculus and all soft deposits, root planing to eliminate subgingival calculus and smooth the tooth surface, and root débridement to eliminate subgingival biofilm and lightly mineralized deposits.</description>
    <arm_group_label>Lactibiane Buccodental, probiotics</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Analyzes of periodontopathogenic bacteria</intervention_name>
    <description>Collection of plaque, to analyze the bacteria in the pocket</description>
    <arm_group_label>Lactibiane Buccodental, probiotics</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>IL1B test</intervention_name>
    <description>susceptibility to periodontal disease (scratch swab onto the tongue) (no invasive)</description>
    <arm_group_label>Lactibiane Buccodental, probiotics</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Salivary Sampling</intervention_name>
    <description>Salivette to chew. To analyse salivary microbiota</description>
    <arm_group_label>Lactibiane Buccodental, probiotics</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Halitosis measure</intervention_name>
    <description>With appropriate device : halimeter</description>
    <arm_group_label>Lactibiane Buccodental, probiotics</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criterion:

          -  Age ≥ 18;

          -  Patient with moderate to severe chronic periodontitis (mean attachment loss ≥ 3 mm),
             generalized (more than 30% of sites with loss of attachment), with presence of at
             least one of three bacterial species the red complex (either Pg, Tf or Td), which,
             according to the practitioner, may be the result of mechanical treatment (ultrasonic
             debridement);

          -  Patient able and willing to participate in the research by complying with the
             procedures of the protocol especially concerning the consumption of the product under
             study and having served it by signing a dated informed consent form;

        Criteria of non-inclusion:

          -  Patient with acute oral lesions or necrotizing ulcerative periodontitis;

          -  Patient who has taken antibiotics in the last 3 months, or who has received treatment
             affecting periodontal tissue in the past month, or on immunosuppressive therapy
             (ciclosporin), antihypertensive (nyfedipine), antiepileptic (phenytoin), under
             biotherapy, or under treatment of hyposialie;

          -  Patient with a medical history or current pathology that, in the opinion of the
             investigator, is likely to interfere with the results of the study or to expose him /
             her to additional risk: unbalanced diabetes, rheumatic fever, disease affecting renal
             or hepatic function, neurological deficiency, immunological disease;

          -  Patient smoking more than 10 cigarettes a day;

          -  Patient with known allergy to at least one of Lactibiane Buccodental® ingredients;

          -  Pregnant or breastfeeding woman or intending to start a pregnancy within 3 months;

          -  a woman who is in a state of childbearing not covered by an active method of
             contraception;

          -  Patient with a psychological or linguistic disability to understand and sign informed
             consent, or to understand and implement the constraints of the study;

          -  Patient participating in another clinical trial, or at the time of exclusion from
             another clinical trial;

          -  Patient under legal protection (tutorship, guardianship) or deprived of his rights
             following the administrative or judicial decision.

          -  Patient not affiliated to a social security scheme
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samira Ait Abdellah</last_name>
    <role>Study Director</role>
    <affiliation>Pileje</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julie Courtiol</last_name>
    <phone>144388838</phone>
    <phone_ext>+33</phone_ext>
    <email>j.courtiol@pileje.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Samira Ait Abdellah</last_name>
    <phone>144388831</phone>
    <phone_ext>+33</phone_ext>
    <email>s.aitabdellah@pileje.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospices Civils de Lyon</name>
      <address>
        <city>Lyon</city>
        <state>Auvergne-Rhône-Alpes</state>
        <zip>69365</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brigitte Grosgogeat, Pr</last_name>
      <phone>04 27 85 40 00</phone>
      <phone_ext>+33</phone_ext>
      <email>brigitte.grosgogeat@univ-lyon1.fr</email>
    </contact>
    <contact_backup>
      <last_name>Kerstin Gritsch,  Dr</last_name>
      <email>kerstin.gritsch@univ-lyon1.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>CHU Hôtel Dieu de Nantes</name>
      <address>
        <city>Nantes</city>
        <state>Pays De La Loire</state>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Assem Soueidan</last_name>
      <phone>240412923</phone>
      <phone_ext>+33</phone_ext>
      <email>assem.soueidan@univ-nantes.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 16, 2018</study_first_submitted>
  <study_first_submitted_qc>May 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 13, 2018</study_first_posted>
  <last_update_submitted>March 11, 2019</last_update_submitted>
  <last_update_submitted_qc>March 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Chronic Periodontitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

